-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ShLMl2GfSFOdHPrO7oII5EexRgSiK/Ed2nbtVkZ5yM7je4B2Vlv7QUGpWgPOqzri WFbqgrVIPgeLiEqI06lGaw== 0001036050-99-002095.txt : 19991018 0001036050-99-002095.hdr.sgml : 19991018 ACCESSION NUMBER: 0001036050-99-002095 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19991015 FILED AS OF DATE: 19991015 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COMBICHEM INC CENTRAL INDEX KEY: 0001002276 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 330617379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 000-23473 FILM NUMBER: 99729458 BUSINESS ADDRESS: STREET 1: 9050 CAMINO STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195300484 MAIL ADDRESS: STREET 1: 9050 CAMINO SANTA FE CITY: SAN DIEGO STATE: CA ZIP: 92121 COMPANY DATA: COMPANY CONFORMED NAME: DUPONT E I DE NEMOURS & CO CENTRAL INDEX KEY: 0000030554 STANDARD INDUSTRIAL CLASSIFICATION: PLASTIC MAIL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) [2820] OTHER IRS NUMBER: 510014090 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 1007 MARKET ST CITY: WILMINGTON STATE: DE ZIP: 19898 BUSINESS PHONE: 3027741000 3 1 FORM 3 +--------+ | FORM 3 | U.S. SECURITIES AND EXCHANGE COMMISSION +--------+ WASHINGTON, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) - -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* E.I. du Pont de Nemours and Company ---------------------------------------------------------------------------- (Last) (First) (Middle) 1007 Market Street ---------------------------------------------------------------------------- (Street) Wilmington, Delaware 19898 ---------------------------------------------------------------------------- (City) (State) (Zip) 2. Date of Event Requiring Statement (Month/Day/Year) 10/05/99 -------------- 3. IRS Identification Number of Reporting Person if an Entity (Voluntary) -------------- 4. Issuer Name and Ticker or Trading Symbol CombiChem, Inc. (Symbol NASDAQ:CCHM) ----------------------------------- 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) [ ] Director [ ] Officer [ ] 10% Owner [ ] Other (give title below) (specify below) (See attached) 6. If Amendment, Date of Original (Month/Day/Year) ---------------------------- 7. Individual or Joint Group Filing (Check Applicable Line) Form Filed by One Reporting Person ---- X Form filed by More than One Reporting Person ---- TABLE I--NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
- -------------------------------------------------------------------------------- 1. Title 2. Amount of 3. Ownership Form: 4. Nature of of Securities Bene- Direct (D) or Indirect Bene- Security ficially Owned Indirect (I) ficial Ownership (Instr. 4) (Instr. 4) (Instr. 5) (Instr. 5) - -------------------------------------------------------------------------------- Common Stock, par value 7,662,280 $0.001 per share (see attached) (I) (see attached) - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - --------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. *If the form is filed by more than one reporting person, see Instruction 5(b)(v). 2 FORM 3 (continued) TABLE II--DERIVATIVE SECURITIES BENEFICIALLY OWNED (e.g., puts, calls, warrants, options, convertible securities)
- ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Derivative 2. Date Exer- 3. Title and Amount of Securities 4. Conversion 5. Ownership 6. Nature of In- Security (Instr. 4) cisable and Underlying Derivative Security or Form of direct Bene- Expiration (Instr. 4) Exercise Derivative ficial Date Price Security: Ownership (Month/Day/ of Direct (D) (Instr. 5) Year) Derivative or In- ---------------------------------------------------- Security direct (I) Date Expira- Amount or (Instr. 5) Exer- tion Title Number of cisable Date Shares - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - -----------------------------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------- Explanation of Responses: This Initial Statement of Beneficial Ownership on Form 3 (this "Form 3") is being filed by E.I. du Pont de Nemours and Company, a Delaware corporation ("Parent"),and DuPont Pharma, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser"), and DPC Newco, Inc., a Delaware corporation and wholly owned subsidiary of Purchaser ("Merger Sub"). On October 5, 1999, Parent, Merger Sub and CombiChem, Inc. a Delaware corporation ("CombiChem") entered into an Agreement and Plan of Merger (the "Merger Agreement") providing for, among other things, the merger of Merger Sub with and into CombiChem. Simultaneously with the execution and delivery of the Merger Agreement, Parent and Merger Sub entered into a Shareholders Agreement, dated as of October 5, 1999 (the "Shareholders Agreement"), with certain major shareholders of CombiChem (the "Major Stockholders") who, as of September 27, 1999 owned 4,549,591 shares of CombiChem Common Stock and options and warrants exercisable for 428,258 shares of CombiChem Common Stock, in the aggregate. Under the Shareholders Agreement, the Major Stockholders have agreed, subject to the terms thereof, to tender all of their shares of CombiChem Common Stock to Merger Sub pursuant to the tender offer described in the Merger Agreement, and to vote their shares in favor of the merger described in the Merger Agreement. The Major Stockholders have also granted Merger Sub a proxy to vote their shares, representing approximately 33.7% of the issued and outstanding shares of CombiChem Common Stock as of September 27, 1999, in favor of the merger. Simultaneously with the execution and delivery of the Merger Agreement, Parent and Merger Sub also entered into a Stock Option Agreement (the "Option Agreement") pursuant to which CombiChem granted to Parent an option to purchase 2,684,431 shares of CombiChem Common Stock, subject to the terms thereof. If this option were to be exercised and these shares were issued to Parent and outstanding, such shares would, together with the shares subject to the Shareholders Agreement, represent approximately 44.1% of the issued and outstanding shares of CombiChem Common Stock as of September 27, 1999. Parent assigned all of its rights under the Merger Agreement, the Shareholders Agreement and the Option Agreement to Purchaser and Purchaser agreed to assume all of the obligations of Parent thereunder. 3 The foregoing summary of the Merger Agreement, the Shareholders Agreement and the Option Agreement is qualified in its entirety by reference to such agreements, which have been filed as exhibits to the Schedule 13D and the Schedule 14D-1 filed with respect to CombiChem on the date hereof and October 12, 1999 respectively. **Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). /s/ John P. Jessup 10/15/99 ------------------------------- -------- **Signature of Reporting Person Date Vice President and Controller on behalf of E.I. du Pont de Nemours and Company 4 Joint Filer Information Names: DuPont Pharma, Inc. DPC Newco, Inc. Address: c/o E.I. du Pont de Nemours and Company 1007 Market Street Wilmington, Delaware 19898 Designated Filer: E.I. du Pont de Nemours and Company Issuer & Ticker Symbol: CombiChem, Inc. (CCHM) Date of Event Requiring Statement: 10/05/99 Signatures: DuPont Pharma, Inc. /s/ A. Lloyd Adams 10/15/99 ------------------------------- ------ A. Lloyd Adams Date Vice President and Assistant Treasurer DPC Newco, Inc. /s/ Steven J. Capolarello 10/15/99 ------------------------------- ------ Steven J. Capolarello Date Vice President and Treasurer 5 -----END PRIVACY-ENHANCED MESSAGE-----